Highlights Valneva

Equities

VLA

FR0004056851

Market Closed - Euronext Paris Other stock markets 11:35:14 2024-04-26 am EDT			5-day change	1st Jan Change
3.444 ^EUR	-0.06%		-5.95%	-27.03%

Apr. 11	Valneva: Deep Track Biotechnology Master holds less than 5% of the capital	CF
Mar. 26	Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valneva: Deep Track Biotechnology Master holds less than 5% of the capital	Apr. 11	CF
Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	Mar. 26	MT
Valneva: Phase 1 trial initiated in the Zika virus	Mar. 26	CF
Valneva SE Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	Mar. 26	CI
ADRs End Higher; XTL Biopharmaceuticals Climbs 129%	Mar. 20	DJ
Valneva SE Raises Revenue Guidance for 2024	Mar. 20	CI
Valneva SE Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Valneva: share price down, forecasts below expectations	Mar. 20	CF
French biotech company Valneva raises product sales guidance	Mar. 20	RE
U.S. CDC Advisory Committee Recommends Use of Valneva?s Single-Dose Chikungunya Vaccine IXCHIQ	Feb. 29	CI
Valneva: Ixchiq vaccine recommended by ACIP	Feb. 29	CF
Valneva Se Announces Earnings Guidance for 2024	Feb. 15	CI
Valneva: 26% increase in product sales in 2023	Feb. 15	CF
VALNEVA : Oddo BHF confirms its recommendation on the stock	Feb. 05	CF
Valneva Sells Tropical Disease Priority Review Voucher for $103 Million	Feb. 05	MT
Valneva Sells Chikungunya Virus Vaccine’s Priority Review Voucher for $103 Million	Feb. 05	MT
Valneva: sale of priority review warrant for Ixchiq	Feb. 05	CF
Valneva: Grimaud holds less than 10% of the capital	Jan. 15	CF
Valneva Se Announces the First Participant Has Been Vaccinated in the Phase 2 Clinical Trial Evaluating the Safety and Immunogenicity in Children of Two Different Dose Levels of Valneva?S Single-Shot Chikungunya Vaccine	Jan. 10	CI
Valneva: pediatric study in chikungunya begins	Jan. 10	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Valneva

Equities

VLA

FR0004056851

Highlights

Filters